C12N 2501/2313
Interleukin-13
Official title: Interleukin-13 (IL-13)
C12N2501/2313 (Interleukin-13) appears on 12 US grants and 42 published applications in this corpus.
Search patents in C12N- Granted patents
- 12
- Published applications
- 42
- Assignees
- 36
- Inventors
- 116
- Latest grant
- 14 Apr 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2014 | 0 | 1 |
| 2015 | 0 | 1 |
| 2016 | 1 | 5 |
| 2017 | 0 | 0 |
| 2018 | 0 | 2 |
| 2019 | 2 | 4 |
| 2020 | 0 | 5 |
| 2021 | 3 | 3 |
| 2022 | 2 | 1 |
| 2023 | 0 | 5 |
| 2024 | 0 | 5 |
| 2025 | 3 | 5 |
| 2026 | 1 | 5 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Modified macrophages, compositions and uses thereof14 Apr 2026US 12,600,949 B2Duogenic Stemcells Corporation
- Cellular targeted label delivery system2 Dec 2025US 12,485,192 B2Cellis AG
- Culture medium and method for inducing iPSC differentiation to obtain macrophages and use thereof26 Aug 2025US 12,398,370 B2Allife Medicine (Beijing) Limited
- Therapeutic methods involving modulating inflammasome activation of myeloid-derived suppressor cells25 Feb 2025US 12,234,480 B2Albert-Ludwigs-Universität Freiburg
- Cellular targeted active ingredient delivery system11 Oct 2022US 11,464,879 B2Cellis AG
- Biomarkers related to immunotherapy efficacy6 Aug 2026US 2026/0224626 A1Kite Pharma, Inc.
- Cell capable of being differentiated into m2 macrophage in tumor tissue and having property such that m2 macrophage differentiated from said cell express inflammatory cytokine, and composition containing said cell6 Aug 2026US 2026/0226412 A1Kyushu University, National University Corporation
- Method to change the polarization of tumor associated macrophages by exposing them to a source of radiation in the presence of magnetosomes9 Apr 2026US 2026/0097075 A1Centre National De La Recherche Scientifique
- Enhanced macrophages2 Apr 2026US 2026/0091058 A1Resolution Therapeutics Limited
- Therapeutic macrophages26 Mar 2026US 2026/0085287 A1Resolution Therapeutics Limited
Most cited
By later US patents
- Induction medium and methods for stem cell culture and therapy3US 9,321,994 B1Commence Bio, Inc. · 2016
- Induction medium and methods for stem cell culture and therapy2US 11,046,929 B2SanBio, Inc. · 2021
- Induction medium and methods for stem cell culture and therapy1US 10,273,449 B2SanBio, Inc. · 2019
- Therapeutic methods involving modulating inflammasome activation of myeloid-derived suppressor cells1US 10,894,061 B2Albert-Ludwigs-Universität Freiburg · 2021